Statins may block an inflammation pathway involved in the development of cancer

FHS
May 30, 2024
12:36 pm

A new study led by investigators from Mass General Cancer Center, a founding member of the Mass General Brigham healthcare system, reveals that statins-;commonly used cholesterol-lowering drugs-;may block a particular pathway involved in the development of cancer that results from chronic inflammation.

Illumina lays out plan to boost growth by helping scientists interpret sequencing data

SAN DIEGO — The unwinding of Illumina’s ill-fated acquisition of Grail earlier this year left investors and the genomics community with a pressing question: What

August 13, 2024

Inside UnitedHealth’s strategy to pressure physicians: $10,000 bonuses and a doctor leaderboard

This is part 4 of Health Care’s Colossus, a series about how UnitedHealth Group wields its unrivaled physician empire to boost its profits and expand

October 16, 2024

Almost a year since Humira biosimilars launched, AbbVie still controls more than 97% of the US market

AbbVie isn’t losing its control of its biggest cash cow Humira (adalimumab) quite yet, despite the influx of eight adalimumab biosimilars vying for market share,

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.